linkedin

Press Releases

Samsung BIO Insight

Samsung Biologics 2022 | Year in Review

Year%20In%20Review_B_221228.png
 

In 2022, Samsung Biologics continued to take the extra mile to build a healthier and better tomorrow. We had a dynamic and exciting year, where we focused all our efforts towards helping to save patients’ lives and build a more sustainable future. Here is a snapshot of the key events and initiatives that defined us in 2022.

 

 

2.jpg 

 

 

Driven. For

 

A BETTER TOMORROW.

 

 1-1.gif

Samsung BIO Insight

Samsung Biologics’ Super Plant 4, How the 

world’s largest biomanufacturing plant will 

drive clients’ success

 1-2.jpg

Company News

Samsung Biologics to purchase land for its 

second Bio Campus

 

 

  

1.jpg 

  

Driven. For

 

ADVANCED TECHNOLOGY.

 

 2-3.jpg 

Samsung BIO Insight

The Power of One | Samsung Biologics’ 

mRNA Capabilities

 2-2.jpg 

Samsung BIO Insight

Exploring Samsung Biologics’ CDO 

capabilities | Bispecific antibodies

   ​​ 

 

 

 

 

Driven. For

 

A SUSTAINABLE LIFE.

 

 3-1.jpg

Samsung BIO Insight

Strategies for a Sustainable Future - Interview with John Rim, CEO and President of Samsung Biologics

 3-2.jpg

Media Focus

Seven pharma CEOs announce new joint action to accelerate net zero healthcare

   ​

 

Year%20In%20Review_B_221228.png

 

In 2022, Samsung Biologics continued to take the extra mile to build a healthier and better tomorrow.

We had a dynamic and exciting year, where we focused all our efforts towards helping to save patients’ lives and build a more sustainable future.

Here is a snapshot of the key events and initiatives that defined us in 2022.